Blood test may identify lung cancer in early stages - Xinhua News Agency
BEIJING, June 2 (Xinhuanet) — A new study suggests that a simple blood test may be able to detect signs of lung cancer in its early stage, which would represent a promising strategy to improve survival rates. The survival rate of people diagnose d
Source: news.xinhuanet.com

Model predicts whether patients will be free of renal cancer 12 years - Science Centric
A UT Southwestern Medical Centre physician and other researchers have developed a unique statistical model that predicts the probability of a patient being cancer free 12 years after initial surgical treatment. The model, known as a nomogram, uses
Source: www.sciencecentric.com

ThromboGenics and BioInvent Report Positive Phase I Results for Anti - Phramalive.com
- Approval Also Received to Start Second Repeat-Dose Phase I Study in Patients With Advanced Cancer ThromboGenics NV and co-development partner BioInvent International AB (Nordic Exchange: BINV) today reported that the results from the first Phase l
Source: www.pharmalive.com

Candidates raise $430K for cancer research - Cincinnati Enquirer
Nine people competing for the Southern Ohio Chapter of the Leukemia & Lymphoma Society’s 2008 Man and Woman of Year raised $430,000 for blood cancer research in 10 weeks. Todd Vollmer of Oakley was named 2008 Man of the Year. Vollmer, an official of
Source: news.enquirer.com

Anemia Drugs May Speed Tumor Growth in Some Cancer Patients - BusinessWeek
SUNDAY, June 1 (HealthDay News) — Drugs used widely to treat anemia in cancer patients may actually speed progression of the cancer in certain individuals, but researchers report they may found a way to determine who those individuals are. “We may
Source: www.businessweek.com

Blood test may detect lung cancer in early stages - Guardian Unlimited
CHICAGO, June 1 (Reuters) - A simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said on Sunday. The two-year survival rate is only about 15
Source: www.guardian.co.uk

Early Data Presented at ASCO Show Potential of RAD001 to Enhance - MSN MoneyCentral
- Novartis to further explore potential of RAD001 in breast cancer by initiating new trial in early 2009 EAST HANOVER, N.J., June 2 /PRNewswire/ — Early proof-of-concept studies presented today show RAD001 (everolimus) may offer a novel treatment
Source: news.moneycentral.msn.com

Keryx Biopharma says perifosine shows promising activity against - RTT News
(RTTNews) - Tuesday, Keryx Biopharmaceuticals Inc. (KERX: News, Chart, Quote ) announced positive results from its Phase 2 study of perifosine or KRX-0401, an oral anti-cancer agent, in patients with relapsed/refractory Waldenstroms macroglobulinemia
Source: www.rttnews.com